{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95v5.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10021","date":"2024-09-13T15:19:03.843Z","role":"Publisher"},{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10021","date":"2020-08-27T16:00:00.000Z","role":"Approver"}],"curationReasons":[{"id":"cg:RecurationFrameworkChange"},{"id":"cg:ErrorClarification"}],"evidence":[{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:3c9d31eb-dbc9-403e-b7b6-4c9f5e2604a4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:43166b3d-9fcd-42e0-9a82-ef8d8ca5dccb","type":"Finding","demonstrates":{"id":"obo:MI_0915"},"dc:description":"Examined interaction between LZTR1 and the RAF1/SHOC2/PPP1CB complex by western blot analysis of the immunoprecipitated samples using antibodies against RAF1, SHOC2, PPP1CB, and PTPN11. Endogenous LZTR1 could bind to RAF1, SHOC2, and PPP1CB but not to PTPN11.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30368668","type":"dc:BibliographicResource","dc:abstract":"RASopathies are a group of developmental disorders caused by mutations in genes that regulate the RAS/MAPK pathway and include Noonan syndrome (NS), Costello syndrome, cardiofaciocutaneous syndrome and other related disorders. Whole exome sequencing studies recently identified LZTR1, PPP1CB and MRAS as new causative genes in RASopathies. However, information on the phenotypes of LZTR1 mutation-positive patients and functional properties of the mutations are limited. To identify variants of LZTR1, PPP1CB, and MRAS, we performed a targeted next-generation sequencing and reexamined previously analyzed exome data in 166 patients with suspected RASopathies. We identified eight LZTR1 variants, including a de novo variant, in seven probands who were suspicious for NS and one known de novo PPP1CB variant in a patient with NS. One of the seven probands had two compound heterozygous LZTR1 variants, suggesting autosomal recessive inheritance. All probands with LZTR1 variants had cardiac defects, including hypertrophic cardiomyopathy and atrial septal defect. Five of the seven probands had short stature or intellectual disabilities. Immunoprecipitation of endogenous LZTR1 followed by western blotting showed that LZTR1 bound to the RAF1-PPP1CB complex. Cells transfected with a small interfering RNA against LZTR1 exhibited decreased levels of RAF1 phosphorylated at Ser259. These are the first results to demonstrate LZTR1 in association with the RAF1-PPP1CB complex as a component of the RAS/MAPK pathway.","dc:creator":"Umeki I","dc:date":"2019","dc:title":"Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes."},"rdfs:label":"Binding to RAF1, SHOC2, PPP1CB"}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:b8cf8d91-6d4b-4da9-a542-dfb109995a8c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b8cf8d91-6d4b-4da9-a542-dfb109995a8c","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Days","allele":{"id":"cggv:d3718fc2-4211-4051-a57b-eac4332fc020","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.881G>T (p.Arg294Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410781339"}},"detectionMethod":"Targeted gene panel (64 genes including 17 associated NS genes)","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0000767","obo:HP_0001642","obo:HP_0000325","obo:HP_0000824","obo:HP_0000347","obo:HP_0001488","obo:HP_0000218","obo:HP_0004322","obo:HP_0000368"],"sex":"Male","variant":{"id":"cggv:2c6fbe2f-fe19-4e27-b66f-95f30d5c2ab2_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d3718fc2-4211-4051-a57b-eac4332fc020"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29959388","type":"dc:BibliographicResource","dc:creator":"Nakaguma M","dc:date":"2019","dc:title":"Noonan syndrome associated with growth hormone deficiency with biallelic LZTR1 variants."}},"rdfs:label":"Patient 1"},{"id":"cggv:2c6fbe2f-fe19-4e27-b66f-95f30d5c2ab2","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:2c6fbe2f-fe19-4e27-b66f-95f30d5c2ab2_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Downgraded to remain conservative."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0b61ff54-8641-46ef-b619-b53fcf40516b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0b61ff54-8641-46ef-b619-b53fcf40516b","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":[{"id":"cggv:044664bf-1f05-4366-b58f-6e45228c2284","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1311G>A (p.Trp437Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118811"}},{"id":"cggv:5cf2222c-6dd2-4228-8a7e-83e84cc0303a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.-38T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA638942431"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Classic Noonan syndrome facial features, fetal fingertip pads","phenotypes":["obo:HP_0000494","obo:HP_0001488","obo:HP_0000368"],"sex":"Male","variant":[{"id":"cggv:33f933d0-ef89-425a-b213-5e307bfe37e9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:5cf2222c-6dd2-4228-8a7e-83e84cc0303a"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30859559","type":"dc:BibliographicResource","dc:abstract":"Noonan syndrome (NS) is characterised by distinctive facial features, heart defects, variable degrees of intellectual disability and other phenotypic manifestations. Although the mode of inheritance is typically dominant, recent studies indicate LZTR1 may be associated with both dominant and recessive forms. Seeking to describe the phenotypic characteristics of LZTR1-associated NS, we searched for likely pathogenic variants using two approaches. First, scrutiny of exomes from 9624 patients recruited by the Deciphering Developmental Disorders (DDDs) study uncovered six dominantly-acting mutations (p.R97L; p.Y136C; p.Y136H, p.N145I, p.S244C; p.G248R) of which five arose de novo, and three patients with compound-heterozygous variants (p.R210*/p.V579M; p.R210*/p.D531N; c.1149+1G>T/p.R688C). One patient also had biallelic loss-of-function mutations in NEB, consistent with a composite phenotype. After removing this complex case, analysis of human phenotype ontology terms indicated significant phenotypic similarities (P = 0.0005), supporting a causal role for LZTR1. Second, targeted sequencing of eight unsolved NS-like cases identified biallelic LZTR1 variants in three further subjects (p.W469*/p.Y749C, p.W437*/c.-38T>A and p.A461D/p.I462T). Our study strengthens the association of LZTR1 with NS, with de novo mutations clustering around the KT1-4 domains. Although LZTR1 variants explain ~0.1% of cases across the DDD cohort, the gene is a relatively common cause of unsolved NS cases where recessive inheritance is suspected.","dc:creator":"Pagnamenta AT","dc:date":"2019","dc:title":"Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome."}},{"id":"cggv:03ce9dc7-837d-452e-bbe0-aea6066699f8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:044664bf-1f05-4366-b58f-6e45228c2284"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"}],"rdfs:label":"O1409410"},{"id":"cggv:33f933d0-ef89-425a-b213-5e307bfe37e9","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:33f933d0-ef89-425a-b213-5e307bfe37e9_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:03ce9dc7-837d-452e-bbe0-aea6066699f8","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:03ce9dc7-837d-452e-bbe0-aea6066699f8_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a83dae29-6c6a-45a8-886b-7db29fc01d63_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a83dae29-6c6a-45a8-886b-7db29fc01d63","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Weeks","ageValue":6,"allele":[{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.1943-256C>T (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10119150"}},{"id":"cggv:089c51fc-ea11-4250-a8df-3999ed3931f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.2062C>G (p.Arg688Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410779158"}}],"phenotypeFreeText":"increased NT, polyhydramnios, priominent Chiari network in the right atrium, HCM, mild muscular hypotonia, broad chest, widely spaced nipples, pes planus, telecanthus, epicanthus, long philtrum, broad neck, low-set, posteriorly angulated ears, mild short stature","previousTesting":true,"previousTestingDescription":"6 weeks-diagnosed HCM\nNGS on PTN11, SOS1, SOS2, RAF1, RIT1, KRAS, NRAS, RRAS, HRAS, SHOC2, LZTR1, A2ML1, BRAF, MAP2K1, MAP2K2, NF1, SPRED1, RASA1. \nfirst pregnancy of healthy non consanguineous parents was lost with tetralogy of Fallot and fetal hydrops","sex":"Female","variant":[{"id":"cggv:80062b9c-4e18-47c1-a340-f1b6c0e0912a_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:089c51fc-ea11-4250-a8df-3999ed3931f2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29469822","type":"dc:BibliographicResource","dc:abstract":"PurposeTo characterize the molecular genetics of autosomal recessive Noonan syndrome.MethodsFamilies underwent phenotyping for features of Noonan syndrome in children and their parents. Two multiplex families underwent linkage analysis. Exome, genome, or multigene panel sequencing was used to identify variants. The molecular consequences of observed splice variants were evaluated by reverse-transcription polymerase chain reaction.ResultsTwelve families with a total of 23 affected children with features of Noonan syndrome were evaluated. The phenotypic range included mildly affected patients, but it was lethal in some, with cardiac disease and leukemia. All of the parents were unaffected. Linkage analysis using a recessive model supported a candidate region in chromosome 22q11, which includes LZTR1, previously shown to harbor mutations in patients with Noonan syndrome inherited in a dominant pattern. Sequencing analyses of 21 live-born patients and a stillbirth identified biallelic pathogenic variants in LZTR1, including putative loss-of-function, missense, and canonical and noncanonical splicing variants in the affected children, with heterozygous, clinically unaffected parents and heterozygous or normal genotypes in unaffected siblings.ConclusionThese clinical and genetic data confirm the existence of a form of Noonan syndrome that is inherited in an autosomal recessive pattern and identify biallelic mutations in LZTR1.Genet Med advance online publication, 22 February 2018; doi:10.1038/gim.2017.249.","dc:creator":"Johnston JJ","dc:date":"2018","dc:title":"Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants."}},{"id":"cggv:1505156f-bb61-4589-bf3e-03ed2f7af2d5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 10"},{"id":"cggv:80062b9c-4e18-47c1-a340-f1b6c0e0912a","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:80062b9c-4e18-47c1-a340-f1b6c0e0912a_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:1505156f-bb61-4589-bf3e-03ed2f7af2d5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:1505156f-bb61-4589-bf3e-03ed2f7af2d5_variant_evidence_item"}],"strengthScore":0,"dc:description":"Already scored in another proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0e7c7fa1-3fb7-4ee6-9059-2f66ffde4b82_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0e7c7fa1-3fb7-4ee6-9059-2f66ffde4b82","type":"Proband","allele":[{"id":"cggv:1220e6ff-d7a0-4964-a4de-eb9f000f0a58","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2178C>A (p.Tyr726Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410779953"}},{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056"}],"detectionMethod":"This family underwent exome sequencing conducted at the Undiagnosed Diseases Network program","phenotypeFreeText":"Proband had prenatal arthrogryposis and polyhydramnios, widely spaced eyes, down-slanted palpebral fissures, midface retrusion, full cheeks, a long philtrum , overfolded ears, and increased posterior angulaiton of the ears. Atrial septal defect, pulmonary artery stenosis, dysplastic pulmonary valve and mild left ventricular and moderate right ventricular hypertrophy. Younger brother had similar features without arthrogryposis. Both had hypotonia, developmental delay, recurrent metabolic acidosis, and mitochondrial complex I +III deficiency","phenotypes":["obo:HP_0011800","obo:HP_0001263","obo:HP_0000396","obo:HP_0001631","obo:HP_0001561","obo:HP_0001942","obo:HP_0005164","obo:HP_0001712","obo:HP_0001667","obo:HP_0011923","obo:HP_0004415","obo:HP_0000343","obo:HP_0000293","obo:HP_0000316","obo:HP_0000358","obo:HP_0002804","obo:HP_0000494","obo:HP_0011924"],"previousTesting":true,"previousTestingDescription":"This family underwent exome sequencing conducted at the Undiagnosed Diseases Network program","sex":"Male","variant":[{"id":"cggv:9be7ea01-feac-4cae-8b7d-4c49ceff0afe_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1220e6ff-d7a0-4964-a4de-eb9f000f0a58"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:5b8a83ed-bf38-4737-8df8-f113c73dca40_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 2: Proband II-4"},{"id":"cggv:5b8a83ed-bf38-4737-8df8-f113c73dca40","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5b8a83ed-bf38-4737-8df8-f113c73dca40_variant_evidence_item"},{"id":"cggv:5b8a83ed-bf38-4737-8df8-f113c73dca40_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"RT-PCR data from lymphoblasts shows that the c.1943-256C>T splice variant retains a 117-bp alternate exon that lies within intron 16 which is predicted to impact the protein."}],"strengthScore":0.5},{"id":"cggv:9be7ea01-feac-4cae-8b7d-4c49ceff0afe","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:9be7ea01-feac-4cae-8b7d-4c49ceff0afe_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e9f4df3e-489a-4fa3-beb2-b338e6a6d855_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e9f4df3e-489a-4fa3-beb2-b338e6a6d855","type":"Proband","allele":[{"id":"cggv:f871c3a7-5096-4320-ad9d-68599ea88787","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.614T>C (p.Ile205Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410780317"}},{"id":"cggv:11f4a4dd-20d0-42cb-8a2a-85217b78262b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.508C>T (p.Arg170Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118450"}}],"phenotypeFreeText":"ASD, valvular and supravalvular pulmonary stenosis, right ventricular HCM, widely spaced eyes, down-slanted palpebral fissures, mild ptosis, low-set ears, increased posterior angulation of the ears, a broad, webbed neck, curly hair, delayed psychomotor development.","previousTesting":true,"previousTestingDescription":"NGS on PTN11, SOS1, SOS2, RAF1, RIT1, KRAS, NRAS, RRAS, HRAS, SHOC2, LZTR1, A2ML1, BRAF, MAP2K1, MAP2K2, NF1, SPRED1, RASA1.","sex":"Male","variant":[{"id":"cggv:927fc449-fe91-4b5a-bc1d-dcab21dad8e0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:11f4a4dd-20d0-42cb-8a2a-85217b78262b"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:25dfae96-88ae-4816-b4bf-a3f49e96d830_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f871c3a7-5096-4320-ad9d-68599ea88787"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 8"},{"id":"cggv:25dfae96-88ae-4816-b4bf-a3f49e96d830","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:25dfae96-88ae-4816-b4bf-a3f49e96d830_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:927fc449-fe91-4b5a-bc1d-dcab21dad8e0","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:927fc449-fe91-4b5a-bc1d-dcab21dad8e0_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:b523f8c0-1236-408e-acea-89e59992fa9f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b523f8c0-1236-408e-acea-89e59992fa9f","type":"Proband","allele":{"id":"cggv:881c8862-38db-4f12-8490-fd344a4107d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2462T>C (p.Ile821Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410781711"}},"detectionMethod":"exome sequenceda tht e Oxford Genomics Cetnre","phenotypeFreeText":"dysmorphic at birth, mild developmental delay, suspected noonan syndrome, small perimembranous VSD and nonobstructive HCM with mild mitral valve prolapse","previousTesting":true,"previousTestingDescription":"exome sequenceda tht e Oxford Genomics Cetnre","sex":"Female","variant":{"id":"cggv:eaab7f78-40e7-4d01-882b-a8ca6e4b1c47_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:881c8862-38db-4f12-8490-fd344a4107d1"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},"rdfs:label":"Family 12"},{"id":"cggv:eaab7f78-40e7-4d01-882b-a8ca6e4b1c47","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:eaab7f78-40e7-4d01-882b-a8ca6e4b1c47_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Downgraded to remain conservative."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:cc7c263f-dba8-4451-96bb-35d995992288_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:cc7c263f-dba8-4451-96bb-35d995992288","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":[{"id":"cggv:4d53b876-22a2-4c7c-ba38-5d9b907f2971","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1591G>A (p.Asp531Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118951"}},{"id":"cggv:762d5238-4117-4f41-9c5b-68018b558d76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.628C>T (p.Arg210Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118525"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0001763","obo:HP_0001634","obo:HP_0000729","obo:HP_0001639","obo:HP_0001263","obo:HP_0001212","obo:HP_0000637"],"sex":"Male","variant":[{"id":"cggv:5923a087-f0d3-4702-83e2-9119fc1d45e3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:4d53b876-22a2-4c7c-ba38-5d9b907f2971"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"},{"id":"cggv:da4eecc1-84e1-456c-a005-d4911db8b196_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:762d5238-4117-4f41-9c5b-68018b558d76"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"}],"rdfs:label":"Patient 272332"},{"id":"cggv:5923a087-f0d3-4702-83e2-9119fc1d45e3","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:5923a087-f0d3-4702-83e2-9119fc1d45e3_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:da4eecc1-84e1-456c-a005-d4911db8b196","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:da4eecc1-84e1-456c-a005-d4911db8b196_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:58ccb17c-c403-479e-bc4b-ecee13c23821_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:58ccb17c-c403-479e-bc4b-ecee13c23821","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":28,"allele":[{"id":"cggv:b44e1212-21e1-44bc-8716-d9422a483003","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.2246A>G (p.Tyr749Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10119315"}},{"id":"cggv:0556f193-4067-4494-bd5e-92480099b2af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1407G>A (p.Trp469Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118876"}}],"phenotypes":["obo:HP_0000455","obo:HP_0001639","obo:HP_0000446"],"sex":"Female","variant":[{"id":"cggv:5fce7717-2fe9-4b36-b2bb-0e59b5501b64_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0556f193-4067-4494-bd5e-92480099b2af"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"},{"id":"cggv:d91fce10-e3d6-47c8-b7b7-8aaef0c7d717_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b44e1212-21e1-44bc-8716-d9422a483003"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"}],"rdfs:label":"O1409412"},{"id":"cggv:d91fce10-e3d6-47c8-b7b7-8aaef0c7d717","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:d91fce10-e3d6-47c8-b7b7-8aaef0c7d717_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:5fce7717-2fe9-4b36-b2bb-0e59b5501b64","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:5fce7717-2fe9-4b36-b2bb-0e59b5501b64_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:02bea860-3237-46d7-8e2c-2b828703c785_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:02bea860-3237-46d7-8e2c-2b828703c785","type":"Proband","allele":{"id":"cggv:bc9a31e8-5969-4c2f-b16f-3f0bc2900874","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.650A>C (p.Glu217Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410780392"}},"detectionMethod":"whole genome sequencing","phenotypeFreeText":"broad neck, developmental delay, widely spaced eyes, strabismus, bilateral epicanthus, down-slanted palpebral fissures, depressed nasal bridge, short and upturned nose, short and broad neck, thickened vermilion of the lips, broad great toes and thumbps and hypermobility, thickened ventricular septum valvular insufficiency and left axis deviation with prolonged QT interval on electroczrdiogram, ventriculomegaly.","previousTestingDescription":"nondysmorphic parents, no known consanguinity. Unaffected female sister","sex":"Female","variant":{"id":"cggv:92f0bdc3-be30-4030-a807-7ea43ba638f9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bc9a31e8-5969-4c2f-b16f-3f0bc2900874"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},"rdfs:label":"Family 9"},{"id":"cggv:92f0bdc3-be30-4030-a807-7ea43ba638f9","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:92f0bdc3-be30-4030-a807-7ea43ba638f9_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Downgraded to remain conservative."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95_seg_el","type":"EvidenceLine","specifiedBy":"GeneValiditySegregationEvidencCriteria","strengthScore":1},{"id":"cggv:d52d7198-7ebf-4d79-9617-7ac8f12c258c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d52d7198-7ebf-4d79-9617-7ac8f12c258c","type":"Proband","allele":[{"id":"cggv:23ad29b3-a3dd-4db7-a300-d035a198713e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.27del (p.Gln10ArgfsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA170538"}},{"id":"cggv:3f46a406-c8a0-4af2-8933-b71b2cb95c84","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1149+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA322328053"}}],"detectionMethod":"exome sequencing","phenotypeFreeText":"depressed, broad nasal bridge, midface retrusion with marked frontal bossing, high anterior hairline, nevus flammeus on forehead, down slanted palpebral fissures, bilateral epicanthus with widely spaced eyes, long philtrum, full sagging cheeks, short neck, broad chest, and relatively short arms and legs","phenotypes":["obo:HP_0002007","obo:HP_0000914","obo:HP_0000431","obo:HP_0009890","obo:HP_0000343","obo:HP_0000494","obo:HP_0000470","obo:HP_0000316","obo:HP_0004322","obo:HP_0007413","obo:HP_0011800","obo:HP_0005280","obo:HP_0000293"],"previousTesting":true,"previousTestingDescription":"Parents non dysmorphic, mother had one stilbirth with polyhydramnios and arthrogryposis-no molecular data","sex":"Female","variant":[{"id":"cggv:e266e483-5d0e-4270-924d-3d0862383858_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:23ad29b3-a3dd-4db7-a300-d035a198713e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:c40a50fc-963e-4c62-9b2b-f0418a9a798c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3f46a406-c8a0-4af2-8933-b71b2cb95c84"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 6"},{"id":"cggv:c40a50fc-963e-4c62-9b2b-f0418a9a798c","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:c40a50fc-963e-4c62-9b2b-f0418a9a798c_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:e266e483-5d0e-4270-924d-3d0862383858","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:e266e483-5d0e-4270-924d-3d0862383858_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:71a4dec1-363d-4eb1-a6ac-39daec7dee86_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:71a4dec1-363d-4eb1-a6ac-39daec7dee86","type":"Proband","allele":{"id":"cggv:9ba9d6bd-4d7d-4853-a5f8-6e24760ebfc8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.1687G>C (p.Glu563Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410777780"}},"detectionMethod":"exome sequencing in Utrecht clinical exome laboratory","phenotypeFreeText":"short broad neck widely spaced eyes, down-slanted palpebral fissures and bilateral ptosis, low-set ears, increased posterior angulation of the ears, and pectus excavatum. Mild short stature. At 3 y.o developed acute lymphoblastic leukemia and is in remission now in his teens, younger brother (II-2) had atrioventricular septal defect, severe biventricular HCM, and a large sacral meningomyelocele and died at day 4 of an inoperable cardiac defect.","sex":"Male","variant":{"id":"cggv:cd4ec109-a8a1-4517-81d3-3ced7759b6b5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9ba9d6bd-4d7d-4853-a5f8-6e24760ebfc8"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},"rdfs:label":"Family 4- II-1"},{"id":"cggv:cd4ec109-a8a1-4517-81d3-3ced7759b6b5","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:cd4ec109-a8a1-4517-81d3-3ced7759b6b5_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"Downgrading to remain conservative."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:bfd9f045-a4b8-4099-9306-366c211e43e3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bfd9f045-a4b8-4099-9306-366c211e43e3","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Days","allele":[{"id":"cggv:73c03fe3-a65b-47a8-817e-97b41bf17586","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1084C>T (p.Arg362Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118715"}},{"id":"cggv:45d629cd-1c7a-42c8-813a-f41c7086a58e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.1149+1G>T (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118733"}}],"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0001639","obo:HP_0001642","obo:HP_0000368","obo:HP_0000316","obo:HP_0000337","obo:HP_0000637","obo:HP_0000465","obo:HP_0000494"],"sex":"Male","variant":[{"id":"cggv:e8463494-ebb4-4537-be0c-35f17b374d85_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:45d629cd-1c7a-42c8-813a-f41c7086a58e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/31182298","type":"dc:BibliographicResource","dc:creator":"Perin F","dc:date":"2019","dc:title":"Two Novel Cases of Autosomal Recessive Noonan Syndrome Associated With LZTR1 Variants."}},{"id":"cggv:b41e4a3e-2dc9-4d04-b32d-cf7d35e0e819_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:73c03fe3-a65b-47a8-817e-97b41bf17586"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/31182298"}],"rdfs:label":"Case 1"},{"id":"cggv:b41e4a3e-2dc9-4d04-b32d-cf7d35e0e819","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:b41e4a3e-2dc9-4d04-b32d-cf7d35e0e819_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:e8463494-ebb4-4537-be0c-35f17b374d85","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:e8463494-ebb4-4537-be0c-35f17b374d85_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:35dcd756-021a-4f3e-9c92-261b1bda84d6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:35dcd756-021a-4f3e-9c92-261b1bda84d6","type":"Proband","allele":[{"id":"cggv:4b8e8b48-627b-4b41-9aa6-7cb00a5117fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2090G>A (p.Arg697Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA501021"}},{"id":"cggv:a7a3357f-5cf3-480f-b5fd-ce1f64a87be9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2407-2A>G (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410781431"}}],"detectionMethod":"exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"cystic hygroma, small ventricular septal defect (VSD). Muscular VSDs, valvular pulmonary stenosis, type II ASD, biventricular HCM. Short stature, down-slanted palprbreal fissures bilateral epicanthus and ptosis, broad neck, wide thorax, low set small cupped ears, narrow palate, pes planus. Also, this indiviudal had twin siblings who had prenatal cystic hygroma and died with hydrops at midgestation.","sex":"Female","variant":[{"id":"cggv:8a009a28-9dbe-4cf2-8546-78c2bcbd04d7_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:4b8e8b48-627b-4b41-9aa6-7cb00a5117fb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:9315b8e9-ef9a-46da-a6bc-0b7a35f61f4c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a7a3357f-5cf3-480f-b5fd-ce1f64a87be9"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 5"},{"id":"cggv:8a009a28-9dbe-4cf2-8546-78c2bcbd04d7","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:8a009a28-9dbe-4cf2-8546-78c2bcbd04d7_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:9315b8e9-ef9a-46da-a6bc-0b7a35f61f4c","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:9315b8e9-ef9a-46da-a6bc-0b7a35f61f4c_variant_evidence_item"},{"id":"cggv:9315b8e9-ef9a-46da-a6bc-0b7a35f61f4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"The splice site variant is in the 5' splice sequence of the last exon. Therefore only 0.5 points were given."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a1863703-2630-45e1-90c7-0c4c7114cdf1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a1863703-2630-45e1-90c7-0c4c7114cdf1","type":"Proband","allele":[{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056"},{"id":"cggv:3ad6322e-523c-4644-8f6e-806436884603","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.2325+1G>A (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410780952"}}],"detectionMethod":"NGS on PTN11, SOS1, SOS2, RAF1, RIT1, KRAS, NRAS, RRAS, HRAS, SHOC2, LZTR1, A2ML1, BRAF, MAP2K1, MAP2K2, NF1, SPRED1, RASA1.","phenotypeFreeText":"cystic hygroma, polyhydramnios were identified prenatally, left HCM, left ventricular outlet stenosis, moderate mitral insufficiency, down-slanted palpebral fissures, broad nasal bridge, upturned nares, low-set ears, incresaed posteriorly angulated ears, broad neck redundant nuchal tissue, wide thorax, pectus excavatum, single left palmar crease","previousTesting":true,"previousTestingDescription":"NGS on PTN11, SOS1, SOS2, RAF1, RIT1, KRAS, NRAS, RRAS, HRAS, SHOC2, LZTR1, A2ML1, BRAF, MAP2K1, MAP2K2, NF1, SPRED1, RASA1. \nnon consanguineous family, family hsitroy was notable for elective termination of fetus with cystic hygroma, hydrops, and congenital heart defect. Mildly broad neck in mother. 3 unaffected siblings without the genotype","sex":"Male","variant":[{"id":"cggv:ca7d30c0-8359-448d-b04a-799a878c6d18_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3ad6322e-523c-4644-8f6e-806436884603"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:5131d5bb-d856-4a85-adbd-a2c463a9861d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:555d40d4-15f2-48e3-97e8-a8407576e056"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 11"},{"id":"cggv:5131d5bb-d856-4a85-adbd-a2c463a9861d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:5131d5bb-d856-4a85-adbd-a2c463a9861d_variant_evidence_item"}],"strengthScore":0,"dc:description":"Already scored in another proband."},{"id":"cggv:ca7d30c0-8359-448d-b04a-799a878c6d18","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:ca7d30c0-8359-448d-b04a-799a878c6d18_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:e515793d-03b4-4cd9-9cef-ad823c3397ae_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e515793d-03b4-4cd9-9cef-ad823c3397ae","type":"Proband","allele":[{"id":"cggv:996687ce-633c-4602-9fbd-e3b93a1221b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2264G>A (p.Arg755Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10119324"}},{"id":"cggv:c942e7f5-446e-4da2-9cd5-abe0548685f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.361C>G (p.His121Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410779341"}}],"phenotypeFreeText":"Proband had prenatal increased NT, postnatal had ventricular and interventricular septum hypertrophy, a VSD, and a small ASD. Short stature, developmental delay, curly hair, low-set ears, increased posterior angulation of the ears, widely spaced eyes, down-slanting palpebral fissures, a narrow nasal bridge and tip, a mildly pointed chin, a broad neck, and chest with mild pectus excavatum, relatively short fingers, and mild hypertrichosis.","phenotypes":["obo:HP_0000446","obo:HP_0000368","obo:HP_0000307","obo:HP_0000475","obo:HP_0011684","obo:HP_0011679","obo:HP_0000767","obo:HP_0010880","obo:HP_0001631","obo:HP_0004322","obo:HP_0000494","obo:HP_0001263","obo:HP_0002212","obo:HP_0011910","obo:HP_0000316","obo:HP_0004554"],"previousTesting":true,"previousTestingDescription":"NGS on PTN11, SOS1, SOS2, RAF1, RIT1, KRAS, NRAS, RRAS, HRAS, SHOC2, LZTR1, A2ML1, BRAF, MAP2K1, MAP2K2, NF1, SPRED1, RASA1. \nproband's brother died neonatally w/ fetal hydrops. Parents nondysmorphic","sex":"Male","variant":[{"id":"cggv:4c89e605-7926-42ad-9a44-cf1c99a1bbba_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c942e7f5-446e-4da2-9cd5-abe0548685f9"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:e12d4164-4849-4c48-ae76-f56d22bcaa9f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:996687ce-633c-4602-9fbd-e3b93a1221b3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 7 II-1"},{"id":"cggv:e12d4164-4849-4c48-ae76-f56d22bcaa9f","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:e12d4164-4849-4c48-ae76-f56d22bcaa9f_variant_evidence_item"}],"strengthScore":0.1},{"id":"cggv:4c89e605-7926-42ad-9a44-cf1c99a1bbba","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:4c89e605-7926-42ad-9a44-cf1c99a1bbba_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2bc4adf5-528f-4204-9283-7cfa17cfee90_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2bc4adf5-528f-4204-9283-7cfa17cfee90","type":"Proband","allele":[{"id":"cggv:bac6af88-6650-4a1e-ac46-38f3444c099d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.628C>T (p.Arg210Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10118525"}},{"id":"cggv:b0ff5f0a-1d52-4cbf-b9fa-83784b9b10e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.3(LZTR1):c.2220-17C>A (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA638942602"}}],"detectionMethod":"This family underwent exome sequencing conducted at the NIH intramural sequencing center.","firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"This family underwent exome sequencing conducted at the NIH intramural sequencing center.","sex":"Female","variant":[{"id":"cggv:b9457d73-c062-42f7-8bc7-70ed5729af69_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bac6af88-6650-4a1e-ac46-38f3444c099d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"},{"id":"cggv:b7f2fe2a-846e-4ac3-9428-5e6d40a1a1c9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b0ff5f0a-1d52-4cbf-b9fa-83784b9b10e0"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29469822"}],"rdfs:label":"Family 1 proband"},{"id":"cggv:b9457d73-c062-42f7-8bc7-70ed5729af69","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:b9457d73-c062-42f7-8bc7-70ed5729af69_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:b7f2fe2a-846e-4ac3-9428-5e6d40a1a1c9","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b7f2fe2a-846e-4ac3-9428-5e6d40a1a1c9_variant_evidence_item"},{"id":"cggv:b7f2fe2a-846e-4ac3-9428-5e6d40a1a1c9_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Found that the c.2220-17C>A splice variant was affecting splicing via RT-PCR and caused p.Tyr741HisfsX89. This causes a stop codon in the last exon in p.830/841 as well as retaining the intron associated with the allele. The allele was alledgedly shown to cause a moderate level of NMD."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f50c36f5-bfa4-4171-b73b-380816f5a3c6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f50c36f5-bfa4-4171-b73b-380816f5a3c6","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":[{"id":"cggv:65810764-52a4-47b2-90e9-3c4e275bd89a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006767.4(LZTR1):c.2062C>T (p.Arg688Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA150702"}},{"id":"cggv:45d629cd-1c7a-42c8-813a-f41c7086a58e"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000635","obo:HP_0001488","obo:HP_0004322","obo:HP_0010780","obo:HP_0000494","obo:HP_0000768","obo:HP_0000368"],"sex":"Male","variant":[{"id":"cggv:041fab8d-382a-46ca-b82e-8df83da530ad_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:45d629cd-1c7a-42c8-813a-f41c7086a58e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"},{"id":"cggv:8e93e48d-296d-43e0-b75b-fb539c5fe224_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:65810764-52a4-47b2-90e9-3c4e275bd89a"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30859559"}],"rdfs:label":"279914"},{"id":"cggv:041fab8d-382a-46ca-b82e-8df83da530ad","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:041fab8d-382a-46ca-b82e-8df83da530ad_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:8e93e48d-296d-43e0-b75b-fb539c5fe224","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:8e93e48d-296d-43e0-b75b-fb539c5fe224_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8969,"specifiedBy":"GeneValidityCriteria9","strengthScore":12.5,"subject":{"id":"cggv:b2d6488b-5314-44ae-87e3-48cd156fa8d6","type":"GeneValidityProposition","disease":"obo:MONDO_0018997","gene":"hgnc:6742","modeOfInheritance":"obo:HP_0000007"},"version":"5.0","dc:description":"LZTR1 was first reported in relation to autosomal recessive Noonan syndrome in 2018 (Johnston et al., PMID: 29469822). The split curation for autosomal dominant Noonan syndrome has been curated separately. 27 variants (missense, nonsense, frameshift, and splicing) that have been reported in 18 probands in 4 publications (PMIDs: 29469822, 29959388, 30859559, 31182298) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by interaction between LZTR1 and the RAF1/SHOC2/PPP1CB complex (PMIDs: 30368668). In summary, there is definitive evidence supporting the relationship between LZTR1 and autosomal recessive Noonan syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Of note, LZTR1 has also been classified as definitive in relation to autosomal dominant Noonan syndrome. Additionally, the ClinGen RASopathy Expert Panel has assessed LZTR1 for associations with both autosomal dominant and recessive forms of Noonan syndrome-like disorder with loose anagen hair, Noonan syndrome with multiple lentigines, Costello syndrome, and Cardiofaciocutaneous syndrome, but no evidence was reported. This gene-disease pair was originally evaluated by the RASopathy GCEP on July 24, 2018. It was re-evaluated on August 27, 2020 (SOP Version 9). As a result of this reevaluation, the classification increased from Limited to Definitive with the addition of additional published cases (PMIDs: 29959388, 30859559, 31182298) and experimental evidence (PMID: 30368668).\nOnly one publication","dc:isVersionOf":{"id":"cggv:7aa1e103-4f77-4c50-99c5-621a6a837b95"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}